期刊文献+

氢化考的松治疗重症社区获得性肺炎的作用 被引量:1

下载PDF
导出
摘要 目的探讨氢化考的松在治疗重症社区获得性肺炎中的作用。方法 49例重症社区获得性肺炎患者,随机分为氢化考的松组和对照组,氢化考的松组在常规治疗的基础上静脉滴注氢化考的松,对比两组病例机械通气时间、ICU停留时间及28天病死率,并对两组病例新发感染及消化道出血两种副作用进行比较。结果氢化考的松组机械通气时间、ICU停留时间明显缩短,差异有统计学意义(P<0.05)。但两组28天病死率比较差异无统计学意义(P>0.05)。两组的副作用新发感染和消化道出血比较差异无统计学意义(P>0.05)。结论氢化考的松可降低重症社区获得性肺炎机械通气时间和ICU住院时间,且不增加新发感染及消化道出血。
作者 邵绍鲲
出处 《海峡药学》 2013年第4期245-246,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献7

  • 1Woodhead M, Blasi F, Thomann R, et aL Guidelines for the man-age- ment of adult lower respiratory tract infecfions[J]. Eur Respir,2005, 26:1138-1180.
  • 2Mandell LA,Wundefink RG,S Ewlg,et aL Infections Diseases So-ciety of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[ J]. Clin In- fect Dis,2007,44:27-72.
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3062
  • 4成人严重感染与感染性休克血流动力学监测及支持指南(草案)[J].中国危重病急救医学,2007,19(3):129-133. 被引量:87
  • 5Martinez R, Menendez R, Reyes S, et aL Factors associated with in- flammatory cytokine patterns in community-acquired pneumonia Eur Respir J,2011,37:393-399.
  • 6Gogosl C,Kotsaki A,Pelekanou A. Early alterations of the innate and adaptive immu~e statuses in sepsis according to the type of underlying infection[J]. Ct Care,2010,14 : B96-R107.
  • 7LowenberSM, Tuyrman J, Bilderbeek J, et aL Rapid immuno-suppres- sive effects of glucocorticoids mediated through Lck and Fyn [J]. Bloed,2005,106(5) :1703-1710.

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:789
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献3144

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部